Statutory Rules
1978 No. 345
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953*
WHEREAS it is provided by sub-section 101 (4) of the National Health Act 1953 that a drug or medicinal preparation that was not a pharmaceutical benefit under that Act immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:
AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953, namely the drugs and medicinal preparations specified in Schedule 3 to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:
NOW THEREFORE I, THE GOVERNOR-GENERAL of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953.
Dated this twenty-eighth day of November 1978.
ZELMAN COHEN
Governor-General
By His Excellency’s Command,
SGD. RALPH J. HUNT
Minister of State for Health
_______
AMENDMENTS OF THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS†
Commencement
1. These Regulations shall come into operation on 1 December 1978.
_________________________________________________________________________________
* Notified in the Commonwealth of Australia Gazette on 30 November 1978.
† Statutory Rules 1960 No. 17 as amended to date. For previous amendments of the National Health (Pharmaceutical Benefits) Regulations see footnote † to Statutory Rules 1978 No. 47 and see also Statutory Rules 1978 Nos. 47, 142 and 153.
15101/78 Cat. No. —Recommended retail price 75c 12/21.11.1978
Schedules 1, 2, 3, 4 and 5
2. Schedules 1, 2, 3, 4 and 5 to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules substituted:
SCHEDULE 1 Sub-regulations 10 (1) and (2)
DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA THAT ARE NOT TO BE SUPPLIED AS OR, EXCEPT AS SPECIALLY PROVIDED, USED IN PHARMACEUTICAL BENEFITS
1 Acetarsol | 56 Busulphan |
2 Acetomenaphthone | 57 Butobarbitone |
3 Acetomenaphthone Tablets | 58 Butylated Hydroxyanisole |
4 Acetrizoic Acid | 59 Butylated Hydroxytoluene |
5 Alcohol, Dehydrated | 60 Caffeine Hydrate |
6 Alcohol (95%) | 61 Calciferol Solution |
7 Allopurinol | 62 Calcium Aminosalicylate |
8 Almond Oil | 63 Calcium Gluconate Injection |
9 Aloes | 64 Calcium Lactate |
10 Alpha Tocopheryl Acetate | 65 Calcium Lactate Tablets |
11 Alprenolol Hydrochloride | 66 Calcium Sodium Lactate |
12 Aluminium Glycinate | 67 Camphor |
13 Aluminium Hydroxide Tablets | 68 Candicidin |
14 Aluminium Phosphate Gel | 69 Caraway |
15 Aluminium Phosphate Gel, Dried | 70 Carbachol Injection |
16 Aluminium Phosphate Tablets | 71 Carbamazepine |
17 Amethocaine Hydrochloride | 72 Carbenoxolone Sodium |
18 Amodiaquine Tablets | 73 Carbimazole |
19 Amphetamine Sulphate | 74 Carbomer |
20 Amphetamine Sulphate Tablets | 75 Carbon Dioxide |
21 Amylobarbitone Sodium Tablets | 76 Carbromal |
22 Antazoline Hydrochloride | 77 Cardamom Fruit |
23 Antazoline Tablets | 78 Cascara |
24 Anti-D (RhO) Immunoglobulin Injection | 79 Cascara Dry Extract |
25 Antimony Sodium Tartrate | 80 Cascara Liquid Extract |
26 Antimony Sodium Tartrate Injection | 81 Cascara Tablets |
27 Apomorphine Hydrochloride | 82 Castor Oil |
28 Apomorphine Injection | 83 Catechu |
29 Arachis Oil | 84 Catgut, Sterilised Surgical |
30 Aspirin and Caffeine Tablets | 85 Cellacephate |
31 Aspirin and Codeine Tablets | 86 Cellulose, Oxidised |
32 Aspirin and Codeine Tablets, Soluble | 87 Cetomacrogol 1000 |
33 Aspirin, Phenacetin and Codeine Tablets | 88 Cetylpyridinium Chloride |
34 Aspirin, Phenacetin and Codeine Tablets, Soluble | 89 Chlorambucil |
35 Atropine Eye Drops | 90 Chlorcyclizine Hydrochloride |
36 Attapulgite, Activated | 91 Chlordiazepoxide Capsules |
37 Azathioprine | 92 Chlordiazepoxide Hydrochloride |
38 Barbitone Sodium | 93 Chlorhexidine Gluconate Solution |
39 Barbitone Sodium Tablets | 94 Chlorhexidine Hydrochloride |
40 Barium Sulphate | 95 Chlormerodrin (197 Hg) Injection |
41 Beclomethasone Cream | 96 Chloroform |
42 Beclomethasone Ointment | 97 Chloroform and Morphine Tincture |
43 Belladonna Dry Extract | 98 Chloroquine Phosphate Injection |
44 Belladonna Herb | 99 Chloroquine Sulphate |
45 Bendrofluazide | 100 Chlorothiazide |
46 Benzhexol Hydrochloride | 101 Chlorotrianisene |
47 Benzyl Alcohol | 102 Chlorotrianisene Capsules |
48 Benzylpenicillin Tablets | 103 Chloroxylenol |
49 Bephenium Hydroxynaphthoate | 104 Chloroxylenol Solution |
50 Betamethasone Sodium Phosphate Tablets | 105 Chlorphenesin |
51 Bethanidine Sulphate | 106 Chlorpheniramine Injection |
52 Biperiden | 107 Chlorproguanil Hydrochloride |
53 Bisacodyl Tablets | 108 Chlorproguanil Tablets |
54 Boric Acid | 109 Chlorpropamide |
55 Bupivacaine Hydrochloride | 110 Chlorthalidone |
| 111 Cholecalciferol |
| 112 Choline Theophyllinate Tablets |
SCHEDULE 1—continued
113 Cinchocaine Hydrochloride | 183 Digitalis Leaf | |
114 Cinnamon | 184 Digitalis, Prepared | |
115 Clofibrate | 185 Digitalis Tablets, Prepared | |
116 Clomiphene Citrate | 186 Digitoxin | |
117 Clomiphene Tablets | 187 Digitoxin Tablets | |
118 Cochineal | 188 Digoxin Paediatric Injection | |
119 Cod-liver Oil | 189 Dihydrocodeine Injection | |
120 Colchicine | 190 Dihydrocodeine Tablets | |
121 Colchicum Corm | 191 Di-iodohydroxyquinoline Tablets | |
122 Colchicum Liquid Extract | 192 Diloxanide Furoate | |
123 Colchicum Tincture | 193 Dilute Alcohols | |
124 Colistin Tablets | 194 Dimenhydrinate | |
125 Colophony | 195 Dimenhydrinate Injection | |
126 Concentrated Peppermint Water | 196 Dimenhydrinate Tablets | |
127 Coriander | 197 Dimercaprol | |
128 Coriander Oil | 198 Dimethisterone | |
129 Corticotropin | 199 Dimethisterone Tablets | |
130 Corticotropin Injection | 200 Dimethyl Phthalate | |
131 Corticotropin Gelatin Injection | 201 Dimethyl Sulphoxide | |
132 Corticotrophin Zinc Injection | 202 Diodone Injection | |
133 Cortisone Acetate | 203 Diphenhydramine Injection | |
134 Cortisone Injection | 204 Diphtheria Vaccine | |
135 Cresol | 205 Diphtheria and Tetanus Vaccine | |
136 Crotamiton | 206 Diphtheria, Tetanus and Pertussis Vaccine | |
137 Cyanocobalamin | 207 Diphtheria, Tetanus and Poliomyelitis Vaccine | |
138 Cyanocobalamin (57Co) | 208 Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine | |
139 Cyanocobalamin (57Co) Solution | 209 Dipipanone Hydrochloride | |
140 Cyanocobalamin (58Co) | 210 Dipipanone Injection | |
141 Cyanocobalamin (58Co) Solution | 211 Dodecyl Gallate | |
142 Cyclobarbitone Calcium | 212 Domiphen Bromide | |
143 Cyclobarbitone Tablets | 213 Dothiepin Capsules | |
144 Cyclomethycaine Sulphate | 214 Dothiepin Hydrochloride | |
145 Cyclopenthiazide | 215 Dydrogesterone | |
146 Cyclopentolate Hydrochloride | 216 Dydrogesterone Tablets | |
147 Cyclopropane | 217 Edrophonium Chloride | |
148 Cycloserine | 218 Edrophonium Injection | |
149 Cycloserine Tablets | 219 Eltor Vaccine | |
150 Dapsone | 220 Emetine and Bismuth Iodide | |
151 Debrisoquine Sulphate | 221 Emetine and Bismuth Iodide Tablets | |
152 Demeclocycline Hydrochloride | 222 Emetine Hydrochloride | |
153 Deoxycortone Acetate | 223 Emetine Injection | |
154 Deoxycortone Acetate Implants | 224 Erythromycin Estolate Capsules | |
155 Deoxycortone Acetate Injection | 225 Ethacrynic Acid | |
156 Dequalinium Acetate | 226 Ethambutol Hydrochloride | |
157 Dequalinium Chloride | 227 Ethambutol Tablets | |
158 Desipramine Hydrochloride | 228 Ethchlorvynol | |
159 Deslanoside | 229 Ethchlorvynol Capsules | |
160 Dexamphetamine Sulphate | 230 Ether Anaesthetic | |
161 Dextran 110 Injection | 231 Ether Solvent | |
162 Dextromethorphan Hydrobromide | 232 Ethionamide | |
163 Dextromethorphan Tablets | 233 Ethionamide Tablets | |
164 Dextropropoxyphene Capsules | 234 Ethisterone | |
165 Dextropropoxyphene Napsylate | 235 Ethisterone Tablets | |
166 Dextrose | 236 Ethopropazine Hydrochloride | |
167 Diamorphine Hydrochloride | 237 Ethotoin | |
168 Diamorphine Injection | 238 Ethotoin Tablets | |
169 Diazepam Capsules | 239 Ethyl Chloride | |
170 Diazoxide | 240 Ethylenediamine Hydrate | |
171 Diazoxide Tablets | 241 Ethylmorphine Hydrochloride | |
172 Dibromopropamidine Isethionate | 242 Ethyloestrenol | |
173 Dichloralphenazone | 243 Ethyl Oleate | |
174 Dichloralphenazone Tablets | 244 Eucalyptus Oil | |
175 Dichlorophen | 245 Eugenol | |
176 Dichlorophen Tablets | 246 Fenfluramine Hydrochloride | |
177 Dichlorphenamide | 247 Fenfluramine Tablets | |
178 Dicophane | 248 Fentanyl Citrate | |
179 Dicyclomine Tablets | 249 Ferric Citrate (59Fe) Injection | |
180 Diethylcarbamazine Citrate |
| |
181 Diethylcarbamazine Tablets |
| |
182 Diethyltoluamide |
| |
SCHEDULE 1—continued
250 Ferrous Fumarate | 313 Hydroxyprogesterone Injection |
251 Ferrous Succinate | 314 Hyoscine Injection |
252 Ferrous Succinate Capsules | 315 Hyoscine Eye Ointment |
253 Ferrous Succinate Tablets | 316 Hyoscine Tablets |
254 Ferrous Sulphate Tablets | 317 Hyoscyamus |
255 Fludrocortisone Acetate | 318 Ibuprofen |
256 Flufenamic Acid | 319 Indigo Carmine |
257 Flufenamic Acid Capsules | 320 Indomethacin |
258 Fluocinolone Acetonide | 321 Influenza Vaccine |
259 Fluorescein Sodium | 322 Influenza Vaccine, Adsorbed |
260 Fluoxymesterone | 323 Industrial Methylated Spirit |
261 Fluphenazine Decanoate | 324 Intracutaneous Typhoid-paratyphoid A & B Vaccine |
262 Fluphenazine Enanthate | 325 Inulin |
263 Fractionated Coconut Oil | 326 Inulin Injection |
264 Fractionated Palm Kernel Oil | 327 Iodinated (125I) Human Albumin Injection |
265 Frusemide | 328 Iodinated (131I) Human Albumin Injection |
266 Furazolidone | 329 Iodipamide Meglumine Injection. |
267 Gallamine Injection | 330 Iodised Oil Fluid Injection |
268 Gallamine Triethiodide | 331 Iopanoic Acid |
269 Gelatin Sponge, Absorbable | 332 Iopanoic Acid Tablets |
270 Gentamicin Sulphate | 333 Iophendylate Injection |
271 Gentian | 334 Iothalamic Acid |
272 Ginger | 335 Ipecacuanha |
273 Glibenclamide | 336 Ipecacuanha, Prepared |
274 Globin Zinc Insulin Injection | 337 Isocarboxazid |
275 Glucagon | 338 Isocarboxazid Tablets |
276 Glutethimide | 339 Isoniazid |
277 Glutethimide Tablets | 340 Isoprenaline Tablets |
278 Gold (198Au) Injection | 341 Isopropyl Alcohol |
279 Griseofulvin | 342 Kanamycin Acid Sulphate |
280 Guanethidine Monosulphate | 343 Kanamycin Sulphate |
281 Halibut-liver Oil | 344 Kaolin, Heavy |
282 Halibut-liver Oil Capsules | 345 Laevulose |
283 Halothane | 346 Laevulose Injection |
284 Halquinol | 347 Lemon Peel, Dried |
285 Helium | 348 Levallorphan Injection |
286 Heparin | 349 Levallorphan Tartrate |
287 Hexachlorophane | 350 Levamisole Hydrochloride |
288 Hexylresorcinol | 351 Levorphanol Injection |
289 Histamine Acid Phosphate | 352 Levorphanol Tablets |
290 Histamine Acid Phosphate Injection | 353 Levorphanol Tartrate |
291 Homatropine Eye Drops | 354 Lignocaine and Adrenaline Injection |
292 Human Albumin | 355 Lincomycin Capsules |
293 Human Albumin, Dried | 356 Lincomycin Hydrochloride |
294 Human Albumin Fraction (Saline) | 357 Liothyronine Sodium |
295 Human Albumin Fraction (Saline), Dried | 358 Liquorice |
296 Human Antihaemophilic Fraction, Dried | 359 Lithium Carbonate |
297 Human Antitetanus Immunoglobulin Injection | 360 Lymecycline |
298 Human Antivaccinia Immunoglobulin Injection | 361 Lymecycline and Procaine Injection |
299 Human Blood, Whole | 362 Lymecycline Capsules |
300 Human Fibrinogen, Dried | 363 Macrosalb (131I) Injection |
301 Human Fibrinogen for Isotopic Labelling, Dried | 364 Macrogol 300 |
302 Human Normal Immunoglobulin Injection | 365 Macrogol 1540 |
303 Human Plasma, Dried | 366 Macrogol 4000 |
304 Human Red Blood Corpuscles, Concentrated | 367 Magnesium Stearate |
305 Human Serum, Dried | 368 Maize Oil |
306 Human Thrombin, Dried | 369 Male Fern |
307 Hydrocortisone Hydrogen Succinate | 370 Male Fern Extract |
308 Hydrocortisone Ointment | 371 Maleic Acid |
309 Hydroflumethiazide | 372 Mannitol |
310 Hydroxocobalamin | 373 Measles Vaccine (Live Attenuated) |
311 Hydroxychloroquine Sulphate | 374 Mefenamic Acid |
312 Hydroxyprogesterone Hexanoate | 375 Mefenamic Acid Capsules |
| 376 Megestrol Acetate |
| 377 Meglumine |
| 378 Meglumine Diatrizoate Injection |
| 379 Meglumine Iothalamate Injection |
SCHEDULE 1—continued
380 Melarsoprol Injection | 450 Novobiocin Tablets | |
381 Melphalan | 451 Nux Vomica | |
382 Melphalan Injection | 452 Octaphonium Chloride | |
383 Mepacrine Hydrochloride | 453 Octyl Gallate | |
384 Mepacrine Tablets | 454 Oestradiol Benzoate | |
385 Mephentermine Injection | 455 Oestradiol Benzoate Injection | |
386 Mephentermine Sulphate | 456 Olive Oil | |
387 Meprobamate | 457 Opium | |
388 Meprobamate Tablets | 458 Opium, Powdered | |
389 Mepyramine Injection | 459 Orange Peel, Dried Bitter | |
390 Mepyramine Malcate | 460 Orciprenaline Injection | |
391 Mepyramine Tablets | 461 Orphenadrine Citrate | |
392 Mercaptopurine | 462 Orphenadrine Hydrochloride | |
393 Mersalyl Acid | 463 Oxygen | |
394 Mersalyl Injection | 464 Oxyphenbutazone | |
395 Metaraminol Injection | 465 Oxyphenbutazone Tablets | |
396 Metaraminol Tartrate | 466 Oxyphencyclimine Hydrochloride | |
397 Methacycline Hydrochloride | 467 Oxyphencyclimine Tablets | |
398 Methandienone | 468 Oxytetracycline Tablets | |
399 Methaqualone | 469 Oxytocin Tablets | |
400 Methisazone | 470 Papaverine Hydrochloride | |
401 Methisazone Mixture | 471 Paramethadione | |
402 Methohexitone Injection | 472 Paramethadione Capsules | |
403 Methoin | 473 Penicillamine | |
404 Methoserpidine | 474 Penicillamine Hydrochloride | |
405 Methoserpidine Tablets | 475 Pentaerythritol Tablets | |
406 Methoxyflurane | 476 Pentagastrin | |
407 Methylamphetamine Hydrochloride | 477 Pentagastrin Injection | |
408 Methylamphetamine Injection | 478 Pentamidine Injection | |
409 Methylamphetamine Tablets | 479 Pentamidine Isethionate | |
410 Methylcellulose 450 | 480 Pentazocine | |
411 Methyldopa | 481 Pentazocine Hydrochloride | |
412 Methyldopate Hydrochloride | 482 Pentazocine Tablets | |
413 Methyldopate Injection | 483 Pentolinium Tartrate | |
414 Methylergometrine Injection | 484 Peppermint Oil | |
415 Methylergometrine Maleate | 485 Perphenazine | |
416 Methylprednisolone Tablets | 486 Perphenazine Tablets | |
417 Methylthiouracil | 487 Pertussis Vaccine, Adsorbed | |
418 Methylthiouracil Tablets | 488 Pethidine Hydrochloride | |
419 Methyprylone | 489 Pethidine Tablets | |
420 Methyprylone Tablets | 490 Phenacetin | |
421 Methysergide Maleate | 491 Phenazocine Hydrobromide | |
422 Metoclopramide Hydrochloride | 492 Phenazocine Injection | |
423 Metronidazole | 493 Phenazocine Tablets | |
424 Metyrapone | 494 Phenazone | |
425 Metyrapone Capsules | 495 Phenelzine Sulphate | |
426 Monosulfiram | 496 Phenformin Hydrochloride | |
427 Monosulfiram Solution | 497 Phenformin Tablets | |
428 Morphine Sulphate Tablets | 498 Phenindamine Tablets | |
429 Nalorphine Hydrobromide | 499 Phenindamine Tartrate | |
430 Nandrolone Decanoate | 500 Phenindione | |
431 Nandrolone Phenylpropionate | 501 Phenmetrazine Hydrochloride | |
432 Neostigmine Bromide | 502 Phenmetrazine Tablets | |
433 Nialamide | 503 Phenobarbitone Sodium Tablets | |
434 Nialamide Tablets | 504 Phenol and Glycerol Injection | |
435 Niclosamide | 505 Phenolphthalein | |
436 Nicotinamide | 506 Phenolphthalein Tablets | |
437 Nicotinic Acid | 507 Phenoxybenzamine Capsules | |
438 Nicoumalone | 508 Phenoxybenzamine Hydrochloride | |
439 Nikethamide | 509 Phenoxymethylpenicillin | |
440 Nikethamide Injection | 510 Phenoxymethylpenicillin Calcium | |
441 Nitrazepam | 511 Phenoxymethylpenicillin Potassium | |
442 Nitrofurazone | 512 Phentolamine Injection | |
443 Nitrous Oxide | 513 Phentolamine Mesylate | |
444 Noradrenaline Injection | 514 Phenylephrine Injection | |
445 Norethandrolone | 515 Phenylpropanolamine Hydrochloride | |
446 Norethandrolone Tablets | 516 Phosphoric Acid | |
447 Noscapine | 517 Physostigmine Eye Drops | |
448 Novobiocin Calcium | 518 Physostigmine Sulphate | |
449 Novobiocin Sodium | 519 Phytomenadione Tablets | |
SCHEDULE 1—continued
520 Pilocarpine Eye Drops | 587 Saccharin Sodium |
521 Piperazine Adipate | 588 Secbutobarbitone |
522 Piperazine Adipate Tablets | 589 L-Selenomethionine (75Se) Injection |
523 Piperazine Citrate | 590 Senna Fruit |
524 Piperazine Phosphate | 591 Senna Tablets |
525 Piperazine Phosphate Tablets | 592 Serum Gonadotropin |
526 Poldine Methylsulphate | 593 Serum Gonadotropin Injection |
527 Poldine Tablets | 594 Sesame Oil |
528 Poliomyelitis Vaccine (Inactivated) | 595 Silver Nitrate, Toughened |
529 Poliomyelitis Vaccine (Oral) | 596 Slow Lithium Carbonate Tablets |
530 Polysorbate 20 | 597 Slow Orphenadrine Citrate Tablets |
531 Polysorbate 60 | 598 Smallpox Vaccine, Dried |
532 Polysorbate 80 | 599 Soda Lime |
533 Potassium Bromide | 600 Sodium Acetrizoate Injection |
534 Potassium Chloride and Dextrose Injection | 601 Sodium Aminosalicylate |
535 Potassium Chloride and Sodium | 602 Sodium Aurothiomalate |
Chloride Injection | 603 Sodium Bicarbonate Compound Tablets |
536 Potassium Chloride Tablets | 604 Sodium Bromide |
537 Potassium Hydroxide | 605 Sodium Calciumedetate |
538 Potassium Nitrate | 606 Sodium Calciumedetate Injection |
539 Povidone-Iodine Solution | 607 Sodium Chloride Tablets |
540 Practolol | 608 Sodium Chromate (51Cr) Solution |
541 Practolol Injection | 609 Sodium Citrate Tablets |
542 Practolol Tablets | 610 Sodium Diatrizoate |
543 Prednisolone Pivalate | 611 Sodium Diatrizoate Injection |
544 Prednisolone Pivalate Injection | 612 Sodium Fluoride |
545 Prednisolone Sodium Phosphate Injection | 613 Sodium Fusidate Capsules |
546 Prednisone | 614 Sodium Hydroxide |
547 Pregelatinised Maize Starch | 615 Sodium Iodide (131I) Injection |
548 Prilocaine Hydrochloride | 616 Sodium Iodide (125I) Solution |
549 Primaquine Phosphate | 617 Sodium Iodide (131I) Solution |
550 Probenecid | 618 Sodium Iodohippurate (131I) Injection |
551 Procainamide Tablets | 619 Sodium Iothalamate Injection |
552 Procaine and Adrenaline Injection | 620 Sodium Lauryl Sulphate |
553 Prochlorperazine Maleate | 621 Sodium Methyl Hydroxybenzoate |
554 Prochlorperazine Mesylate | 622 Sodium Pertechnetate (00111Tc) Injection |
555 Procyclidine Hydrochloride | 623 Sodium Phosphate (32P) Injection |
556 Progesterone | 624 Sodium Propionate |
557 Progesterone Injection | 625 Sodium Propyl Hydroxybenzoate |
558 Proguanil Hydrochloride | 626 Sodium Stibogluconate |
559 Promazine Hydrochloride | 627 Sodium Stibogluconate Injection |
560 Promazine Injection | 628 Sodium Thiosulphate |
561 Promazine Tablets | 629 Sorbitol |
562 Promethazine Theoclate | 630 Sorbitol Injection |
563 Propanidid | 631 Spironolactone |
564 Propantheline Bromide | 632 Stanolone |
565 Propicillin Potassium | 633 Stanolone Tablets |
566 Propicillin Tablets | 634 Sterilizable Maize Starch |
567 Propranolol Hydrochloride | 635 Stilboestrol |
568 Propyl Gallate | 636 Stramonium |
569 Propyliodone | 637 Strong Potassium Chloride Solution |
570 Propyliodone Injection | 638 Sulfadoxine |
571 Propyliodone Oily Injection | 639 Sulphacetamide Eye Ointment |
572 Propylthiouracil | 640 Sulphadimethoxine |
573 Pyrazinamide | 641 Sulphadimethoxine Tablets |
574 Pyridostigmine Bromide | 642 Sulphadimidine Injection |
575 Pyrimethamine | 643 Sulphadimidine Sodium |
576 Pyroxylin | 644 Sulphamethoxydiazine |
577 Quillaia | 645 Sulphamethoxypridazine |
578 Quinine Bisulphate | 646 Sulphapyridine |
579 Quinine Dihydrochloride | 647 Sulphinpyrazone |
580 Quinine Dihydrochloride Injection | 648 Sulphobromophthalein Sodium |
581 Quinine Hydrochloride | 649 Sulphomyxin Injection |
582 Quinine Sulphate | 650 Sulphomyxin Sodium |
583 Rabies Antiserum | 651 Sulthiame |
584 Rabies Vaccine | 652 Suxamethonium. Bromide |
585 Rubella Vaccine (Live Attenuated) | 653 Suxamethonium Bromide Injection |
586 Saccharin | 654 Suxamethonium Chloride |
| 655 Suxamethonium Chloride Injection |
| 656 Tartaric Acid |
SCHEDULE 1—continued
657 Terpineol | 688 Triclofos Tablets |
658 Testosterone | 689 Trimeprazine Tartrate |
659 Testosterone Implants | 690 Trimipramine Maleate |
660 Testosterone Phenylpropionate Injection | 691 Trisodium Edetate Injection |
661 Tetanus and Pertussis Vaccine | 692 Tropicamide |
662 Tetanus Antitoxin | 693 Troxidone |
663 Tetanus Vaccine | 694 Troxidone Capsules |
664 Tetrachloroethylene | 695 Tuberculin, Old |
665 Tetrachloroethylene Capsules | 696 Tubocurarine Chloride |
666 Tetracycline Injections | 697 Tubocurarine Injection |
667 Tetracycline Tablets | 698 Turpentine Oil |
668 Theobroma Oil | 699 Typhoid and Tetanus Vaccine |
669 Thiabendazole | 700 Typhoid-paratyphoid A and B Vaccine |
670 Thiambutosine | 701 Typhoid-paratyphoid A and B and Tetanus Vaccine |
671 Thiambutosine Tablets | 702 Typhoid-paratyphoid A and B and Cholera Vaccine |
672 Thiamine Hydrochloride | 703 Undecenoic Acid |
673 Thiomersal | 704 Urea Injection |
674 Thiopentone Sodium | 705 Vasopressin Injection |
675 Thiopentone Injection | 706 Vinyl Ether |
676 Thymoxamine Hydrochloride | 707 Viomycin Sulphate |
677 Thymoxamine Tablets | 708 Viomycin Sulphate Injection |
678 Thyroid | 709 Vitamin A Ester Concentrate |
679 Thyroid Tablets | 710 Warfarin Sodium |
680 Thyroxine Sodium | 711 Xenon (133Xe) Injection |
681 Tolazoline Hydrochloride | 712 Xylose |
682 Tolazoline Tablets | 713 Yellow Fever Vaccine |
683 Tolbutamide | 714 Zinc Undecenoate |
684 Tolnaftate | 715 Zinc Undecenoate Ointment |
685 Tranylcypromine Sulphate |
|
686 Triamterene Capsules |
|
687 Trichloroethylene |
|
SCHEDULE 2 Sub-regulations 10 (3) and (4)
ALLOWABLE COMPOUNDS (IF ANY) OF CERTAIN DRUGS OR MEDICINAL
PREPARATIONS
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
1 | Acepifylline.................. | — |
2 | Acetylcysteine................. | — |
3 | Acetylsulphafurazole............ | — |
4 | Acrylic Resin................. | — |
5 | Adrenaline Hydrochloride......... | — |
6 | “ALBUMAID XP”............. | — |
7 | Alginic Acid Compound.......... | — |
8 | Aluminium Sodium Silicate........ | — |
9 | Amiloride Hydrochloride.......... | Hydrochlorothiazide, B.P., with Amiloride Hydrochloride |
10 | Aminocaproic Acid............. | — |
11 | “ AMINOFUSIN 5% ”........... | — |
12 | “ AMINOFUSIN 10% ”.......... | — |
13 | “ AMINOFUSIN A 5% WITH ALCOHOL ” | — |
| — | |
14 | “ AMINOFUSIN L 10% ”......... | — |
15 | “ AMINOFUSIN STANDARD ”.... | — |
16 | “ AMINOGRAN FOOD SUPPLEMENT ” | — |
17 | “ AMINOGRAN MINERAL MIXTURE ” | — |
18 | Amoxycillin Trihydrate........... | Purified Water, B.P., with Amoxycillin Trihydrate |
19 | Amphotericin................. | — |
20 | Ampicillin................... |
|
21 | Ampicillin Trihydrate............ | Purified Water, B.P., with Ampicillin Trihydrate |
22 | Antazoline Sulphate............. | Naphazoline Nitrate with Antazoline Sulphate |
23 | Ascorbic Acid................. | Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary |
|
| Ferrous Sulphate mixture Prescribers’ List |
|
| Ferrous Sulphate mixture Prescribers’ List Children’s Section |
24 | Bacitracin.................... | Neomycin Sulphate with Polymyxin B Sulphate and Bacitracin |
25 | Bacitracin Zinc................ | Neomycin Undecenoate with Bacitracin Zinc |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Bacitracin Zinc |
26 | “ BANISH ”.................. | — |
27 | Beclomethasone Dipropionate | — |
28 | Benzathine Penicillin............ | Procaine Penicillin with Benzylpenicillin Potassium and Benzathine Penicillin |
29 | Benzylpenicillin Potassium........ | Benzathine Penicillin with Procaine Penicillin and Benzylpenicillin Potassium |
30 | Benzylpenicillin Sodium.......... | Procaine Penicillin with Benzylpenicillin Sodium |
31 | Betamethasone................ | Betamethasone Acetate with Betamethasone |
32 | Betamethasone Acetate........... | Betamethasone with Betamethasone Acetate |
33 | Betamethasone Dipropionate | — |
34 | Betamethasone Sodium Phosphate | — |
35 | Betamethasone Phosphate......... | — |
36 | Betamethasone Valerate.......... | — |
37 | Bisacodyl.................... | Dioctyl Sodium Sulphosuccinate, B.P.C., with Bisacodyl |
38 | Brompheniramine Malcate......... | — |
39 | Bufexamac................... | — |
40 | Calciferol.................... | — |
41 | Calcium Chloride............... | Sodium Chloride, B.P., with Potassium Chloride and Calcium Chloride in Water for Injections |
42 | Calcium Lactate-Gluconate........ | Calcium Carbonate, B.P., with Calcium Lactate-Gluconate |
SCHEDULE 2—continued
Column I | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
43 | Carbachol.................... | Hypromellose 4500 with Carbachol |
44 | Carbidopa.................... | Levodopa, B.P., with Carbidopa |
45 | Carbinoxamine Maleate........... | — |
46 | Cephalexin.................... | Purified Water, B.P., with Cephalexin |
47 | Cephradine.................... | Purified Water, B.P., with Cephradine |
48 | Ceratonia, B.P.C. 1949............ | — |
49 | Chloramine, B.P.C............... | — |
50 | Chloramphenicol................ | Polymyxin B Sulphate with Chloramphenicol |
51 | Chloramphenicol Palmitate, B.P.C. | — |
52 | Chloramphenicol Stearate.......... | — |
53 | Chlorhexidine Gluconate .......... | — |
54 | Chlorpheniramine Maleate......... | — |
55 | Chlorpromazine Hydrochloride | — |
56 | Choline Theophyllinate........... | Guaiphenesin, B.P.C, with Choline Theophyllinate |
57 | Clemizole Tannate............... | — |
58 | Clindamycin Palmitate Hydrochloride | Purified Water, B.P., with Clindamycin Palmitate Hydrochloride |
| ||
59 | Clotrimazole.................. | — |
60 | Cloxacillin Sodium.............. | Purified Water, B.P., with Cloxacillin Sodium |
61 | Colistin Sulphate................ | Neomycin Sulphate with Colistin Sulphate |
62 | Cortisone Acetate............... | — |
63 | Cyclizine Hydrochloride........... | Ergotamine Tartrate with Caffeine and Cyclizine Hydrochloride |
64 | Cyproheptadine Hydrochloride | — |
65 | Danthron..................... | Dioctyl Sodium Sulphosuccinate, B.P.C, with Danthron |
66 | Demecarium Bromide............ | — |
67 | Desmopressin.................. | — |
68 | Dexamethasone................. | Framycetin Sulphate with Gramicidin and Dexamethasone |
69 | Dexamethasone Metasulphobenzoate | Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate |
70 | Dexchlorpheniramine Maleate | — |
71 | Dextropropoxyphene Hydrochloride | Paracetamol with Dextropropoxyphene Hydrochloride |
72 | Diazepam.................... | — |
73 | Dicyclomine Hydrochloride........ | Doxylamine Succinate with Pyridoxine Hydrochloride and Dicyclomine Hydrochloride |
74 | Dienoestrol................... | — |
75 | “ DIGESTELACT ”.............. | — |
76 | Digoxin...................... | — |
77 | Dihydrocodeine Tartrate........... | — |
78 | Dimethicone, B.P.C.............. | — |
79 | Dioctyl Sodium Sulphosuccinate, B.P.C. | Bisacodyl with Dioctyl Sodium Sulphosuccinate, B.P.C. |
| Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C. | |
80 | Diphenhydramine Hydrochloride | Ergotamine Tartrate with Caffeine Citrate and Diphenhydramine Hydrochloride |
81 | Diphenoxylate Hydrochloride | Atropine Sulphate with Diphenoxylate Hydrochloride |
82 | Diphenylpyraline Hydrochloride | — |
83 | Diphtheria Vaccine Adsorbed | Diphtheria and Tetanus Vaccine, Adsorbed |
|
| Diphtheria, Tetanus and Pertussis Vaccine, Adsorbed |
84 | Doxylamine Succinate............ | Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate |
85 | Ecothiopate Iodide............... | — |
86 | Ergometrine Maleate............. | Oxytocin with Ergometrine Maleate |
87 | Ergotamine Tartrate.............. | Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate |
|
| Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
|
| Caffeine with Ergotamine Tartrate |
|
| Caffeine with Meclozine Hydrochloride and Ergotamine Tartrate |
88 | Erythromycin Estolate............ | — |
89 | Erythromycin Stearate............ | — |
90 | Ethinyloestradiol................ | Ethynodiol Diacetate with Ethinyloestradiol |
|
| Lynoestrenol with Ethinyloestradiol |
|
| Norethisterone with Ethinyloestradiol |
|
| Norethisterone Acetate with Ethinyloestradiol |
|
| Norgestrel with Ethinyloestradiol |
91 | Ethosuximide.................. | — |
92 | Ethynodiol Diacetate............. | Ethinyloestradiol with Ethynodiol Diacetate |
|
| Mestranol with Ethynodiol Diacetate |
93 | Fenoterol Hydrobromide........... | — |
94 | Ferrous Aminoacetosulphate | — |
95 | Fluclorolone Acetonide........... | — |
96 | Flumethasone Pivalate............ | Clioquinol with Flumethasone Pivalate |
97 | Fluocortolone Hexanoate.......... | Fluocortolone Pivalate with Fluocortolone Hexanoate |
98 | Fluocortolone Pivalate............ | Fluocortolone Hexanoate with Fluocortolone Pivalate |
99 | Fluphenazine Hydrochloride........ | — |
100 | Folic Acid.................... | Ferrous Sulphate (Dried), B.P., with Folic Acid, B.P. |
101 | Framycetin Sulphate............. | Dexamethasone with Framycetin Sulphate and Gramicidin |
|
| Gramicidin and Dexamethasone Metasulphobenzoate with Framycetin Sulphate |
102 | Fusidic Acid................... | — |
103 | “ GALACTOMIN, FORMULA No. 17 ” | — |
104 | “ GALACTOMIN, FORMULA No. 19 ” | — |
105 | Gamma Benzene Hexachloride | — |
106 | Gamma Benzene Hexachloride Cream, B.P. | — |
107 | Glucose and Ketone Indicator | — |
108 | Glucose Indicator, Urine........... | — |
109 | “ GLUCOSE NUTRAMIGEN ” | — |
110 | Goats’ Milk................... | — |
111 | Goats’ Milk, Dehydrated........... | — |
112 | Gramicidin.................... | Framycetin Sulphate with Dexamethasone and Gramicidin |
|
| Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin |
|
| Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin |
113 | Guaiphenesin, B.P.C............. | Theophylline with Guaiphenesin, B.P.C. |
114 | Hexamine Mandelate............. | — |
115 | Hydrochlorothiazide, B.P.......... | Amiloride Hydrochloride with Hydrochlorothiazide, B.P. |
|
| Triamterene, B.P., with Hydrochlorothiazide, B.P. |
116 | Hydrocortisone | Natamycin with Neomycin Sulphate and Hydrocortisone |
|
| Neomycin Sulphate with Hydrocortisone |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Hydrocortisone |
117 | Hydrocortisone Acetate........... | Neomycin Sulphate with Hydrocortisone Acetate |
|
| Oxytetracycline Hydrochloride and Hydrocortisone Acetate |
118 | Hyoscine Hydrobromide........... | Atropine Sulphate, B.P., with Hyoscyamine Sulphate and Hyoscine Hydrobromide, B.P. |
|
| Papaveretum with Hyoscine Hydrobromide, B.P. |
119 | Hyoscyamine Sulphate ........... | Atropine Sulphate, B.P., with Hyoscine Hydrobromide, B.P., and Hyoscyamine Sulphate |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
120 | Idoxuridine................... | — |
121 | “ ISOMIL ”................... | — |
122 | Isoprenaline Hydrochloride......... | — |
123 | “ KETOVITE ” Liquid............ | — |
124 | Lauryldimethylbenzyl Ammonium Chloride | “ TERIC N8 ” with Lauryldimethylbenzyl Ammonium Chloride |
125 | Levodopa, B.P................. | Benserazide with Levodopa, B.P. |
|
| Carbidopa with Levodopa, B.P. |
126 | “LOCASOL”.................. | — |
127 | “LOFENALAC”................ | — |
128 | Lynoestrenol.................. | Ethinyloestradiol with Lynoestrenol |
|
| Mestranol with Lynoestrenol |
129 | Lypressin | — |
130 | Magnesium Aluminium Hydroxide | — |
131 | Magnesium Chloride............. | Sodium Chloride with Sodium Acetate, Sodium Gluconate, Potassium Chloride and Magnesium Chloride |
132 | Magnesium Hydroxide, B.P.C. | Aluminium Hydroxide Gel Dried with Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel Dried with Magnesium Trisilicate and Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C., and Oxethazaine |
133 | Mebhydrolin Napadisylate, B.P.C. 1968 | — |
134 | Meclozine Hydrochloride.......... | Ergotamine Tartrate with Caffeine and Meclozine Hydrochloride |
135 | Medrysone.................... | — |
136 | Mestranol.................... | Ethynodiol Diacetate with Mestranol |
|
| Lynoestrenol with Mestranol |
|
| Norethisterone with Mestranol |
|
| Norethynodrel with Mestranol |
137 | Methylprednisolone.............. | — |
138 | Methylprednisolone Acetate | — |
139 | Miconazole Nitrate.............. | — |
140 | Morphine Tartrate............... | Tacrine with Morphine Tartrate |
141 | Nalidixic Acid, B.P.C............. | — |
142 | Naphazoline Hydrochloride | — |
143 | Naphazoline Nitrate.............. | Antazoline Sulphate with Naphazoline Nitrate |
144 | Natamycin.................... | Neomycin Sulphate with Hydrocortisone and Natamycin |
145 | Neomycin Sulphate.............. | Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate |
|
| Colistin Sulphate with Neomycin Sulphate |
|
| Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate |
|
| Hydrocortisone Acetate with Neomycin Sulphate |
|
| Hydrocortisone with Neomycin Sulphate |
|
| Natamycin with Hydrocortisone and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Gramicidin and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Hydrocortisone and Neomycin Sulphate |
146 | Neomycin Undecenoate | Bacitracin Zinc with Neomycin Undecenoate |
147 | Neostigmine Methylsulphate | — |
148 | Nitrofurantoin.................. | — |
149 | Noradrenaline Acid Tartrate | — |
150 | Norethisterone................. | Ethinyloestradiol with Norethisterone |
|
| Mestranol with Norethisterone |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
151 | Norethisterone Acetate............ | Ethinyloestradiol with Norethisterone Acetate |
152 | Norethynodrel................. | Mestranol with Norethynodrel |
153 | Norgestrel.................... | Ethinyloestradiol with Norgestrel |
154 | Nortriptyline Hydrochloride | — |
155 | Nystatin..................... | Gramicidin with Neomycin Sulphate, Triamcinolone Acetonide and Nystatin |
|
| Oxytetracycline Dihydrate with Nystatin |
|
| Tetracycline, B.P.C., with a buffering agent and Nystatin |
|
| Tetracycline Hydrochloride with Nystatin |
156 | Orciprenaline Sulphate............ | — |
157 | Oxytetracycline Dihydrate......... | Nystatin with Oxytetracycline Dihydrate |
158 | Oxytetracycline Hydrochloride, B.P. | Hydrocortisone Acetate with Oxytetracycline Hydrochloride, B.P. |
|
| Polymyxin B Sulphate with Oxytetracycline Hydrochloride, B.P. |
159 | Oxethazaine................... | Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C, and Oxethazaine |
160 | Oxytocin..................... | Ergometrine Maleate with Oxytocin |
161 | Pancreatin.................... | — |
162 | Pancreatin Enzyme, 4 times U.S.N.F.XIII strength | — |
163 | Papaveretum, B.P.C.............. | Hyoscine Hydrobromide with Papaveretum, B.P.C. |
164 | Pericyazine................... | — |
165 | Pertussis Vaccine............... | Diphtheria, Tetanus and Pertussis Vaccine, Adsorbed |
166 | Phenethicillin Potassium........... | Purified Water, B.P., with Phenethicillin Potassium |
167 | Pheniramine Maleate............. | — |
168 | Phenoxymethylpenicillin (Benzathine or Hydrabamine salt) |
|
169 | Phenytoin, B.P.C................ | — |
170 | Pholcodine | — |
171 | Pituitary (Posterior Lobe), Powdered, B.P.C. | — |
172 | “ PK AID I ”.................. | — |
173 | “ PK AID II ”.................. | — |
174 | Plasma Substitute (Polypeptide) | — |
175 | Polyisobutylene................ | — |
176 | Polymyxin B Sulphate............ | Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate |
|
| Bacitracin Zinc with Neomycin Sulphate and Polymyxin B Sulphate |
|
| Chloramphenicol with Polymyxin B Sulphate |
|
| Neomycin Sulphate with Gramicidin and Polymyxin R Sulphate |
|
| Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate |
|
| Oxytetracycline Hydrochloride with Polymyxin 15 Sulphate |
|
| Propylene Glycol with Acetic Acid and Polymyxin B Sulphate |
177 | Polyvinylpyrrolidone and Vinyl Acetate Copolymer | — |
178 | Prednisolone.................. | — |
179 | Prednisolone Acetate............. | Phenylephrine Hydrochloride, B.P., with Prednisolone Acetate |
180 | Prednisolone Sodium Phosphate | — |
181 | “ PREGESTIMIL ”.............. | — |
182 | Primidone.................... | — |
183 | Procaine Penicillin.............. | Benzathine Penicillin with Benzylpenicillin Potassium and Procaine Penicillin |
|
| Benzylpenicillin Sodium with Procaine Penicillin |
184 | Promethazine Hydrochloride | — |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
185 | “ PROSOBEE ”................ |
|
186 | Pseudoephedrine Hydrochloride | — |
187 | Pyrantel Embonate.............. | — |
188 | Pyridoxine Hydrochloride.......... | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride |
189 | Salbutamol.................... | — |
190 | Salbutamol Sulphate............. | — |
191 | Sodium Acetate................. | Sodium Chloride with Potassium Chloride, Magnesium Chloride, Sodium Gluconate and Sodium Acetate |
192 | Sodium Acid Citrate............. | — |
193 | Sodium Carboxymethylcellulose | Gelatin and Pectin with Sodium Carboxymethylcellulose |
194 | Sodium Gluconate............... | Sodium Chloride with Sodium Acetate, Potassium Chloride, Magnesium Chloride and Sodium Gluconate |
195 | Sodium Lactate................. | Potassium Chloride with Anhydrous Dextrose and Sodium Lactate |
196 | “SOYALAC”.................. | — |
197 | Sterculia..................... | — |
198 | Sulphafurazole................. | — |
199 | Sulphamethizole................ | — |
200 | Sulphamethoxazole.............. | Trimethoprim with Sulphamethoxazole |
201 | Sulphaphenazole, B.P.C........... | — |
202 | Surgical Cement................ | — |
203 | Surgical Cement Solvent........... | — |
204 | Tacrine...................... | Morphine Sulphate with Tacrine |
|
| Morphine Tartrate with Tacrine |
205 | Terbutaline Sulphate............. | — |
206 | “TERIC N8”.................. | Lauryldimethylbenzyl Ammonium Chloride with “TERIC N8” |
207 | Testosterone Decanoate........... | Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
208 | Testosterone Isocaproate........... | Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
209 | Testosterone Phenylpropionate | Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
210 | Testosterone Propionate........... | Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
211 | Tetanus Vaccine, Adsorbed......... | Diphtheria and Tetanus Vaccine, Adsorbed |
|
| Diphtheria, Pertussis and Tetanus Vaccine, Adsorbed |
212 | Tetracyline, B.P.C............... | Tetracycline, B.P.C., with a buffering agent |
|
| Tetracycline, B.P.C., with a buffering agent and Nystatin |
213 | Tetracycline Hydrochloride......... | Tetracycline Hydrochloride with Nystatin |
214 | Thioridazine Hydrochloride | — |
215 | Thiotepa..................... | — |
216 | Triamcinolone Acetonide.......... | Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide |
217 | Triamterene B.P................ | Hydrochlorothiazide, B.P. with Triamterene, B.P. |
218 | Triclofos Sodium............... | — |
219 | Trifluoperazine Hydrochloride | — |
220 | Triglycerides Oil, Medium Chain | — |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
221 | “TRIGLYDE”................. |
|
222 | Trimethoprim.................. | Sulphamethoxazole with Trimethoprim |
223 | Triprolidine Hydrochloride......... | — |
224 | Urea........................ | — |
225 | Viprynium Embonate ............ | — |
226 | “ZERODOR”.................. | — |
227 | “ZOFF”..................... | — |
SCHEDULE 3 Sub-regulation 10 (2)
regulation 11 and Sub-regulation 35 (1)
DRUGS AND MEDICINAL PREPARATIONS ADDITIONAL TO THE DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA
1 Acepifylline | 59 Cade Oil, B.P.C. |
2 Acetazolamide Sodium | 60 Caffeine Citrate, B.P.C. 1959 |
3 Acetohexamide | 61 Calcitonin (Salmon Synthetic) |
4 Acetylcholine Chloride | 62 Calcium Folinate |
5 Acetylcysteine | 63 Calcium Glubionate |
6 Acetylsulphafurazole | 64 Calcium Lactate-Gluconate |
7 Acidified Golden Syrup, A.P.F. 1955 | 65 Capsicum Ointment, B.P.C. |
8 Acriflavine, B.P.C. 1963 | 66 Carbidopa |
9 Acrylic Resin | 67 Carbinoxamine Maleate |
10 Adrenaline Hydrochloride | 68 Cardamom Aromatic Tincture, B.P.C. |
11 “ ALBUMAID XP ” | 69 Catechu Tincture, B.P.C. |
12 Alginic Acid Compound | 70 Cephazolin Sodium |
13 Aloxiprin | 71 Cephradine |
14 Aluminium Acetate Solution, B.P.C | 72 Ceratonia, B.P.C. 1949 |
15 Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex | 73 Charcoal, B.P.C. |
16 Aluminium Sodium Silicate | 74 Chloramphenicol Palmitate, B.P.C. |
17 Amantadine Hydrochloride | 75 Chlorhexidine Gluconate |
18 Amaranth, B.P.C. 1954 | 76 Chlorinated Lime, B.P.C. |
19 Ambenonium Chloride | 77 Chlormethiazole |
20 Amiloride Hydrochloride | 78 Chlormethiazole Edisylate |
21 Aminacrine Hydrochloride, B.P. 1968 | 79 Cholestyramine |
22 “ AMINOFUSIN 5% ” | 80 Cimetidine |
23 “ AMINOFUSIN 10% ” | 81 Clemastine Fumarate |
24 “ AMINOFUSIN A 5% WITH ALCOHOL ” | 82 Clemizole Hydrochloride |
25 “ AMINOFUSIN L 10% ” | 83 Clemizole Tannate |
26 “ AMINOFUSIN STANDARD ” | 84 Clindamycin Hydrochloride |
27 “ AMINOGRAN FOOD | 85 Clindamycin Palmitate Hydrochloride |
SUPPLEMENT ” | 86 Clonazepam |
28 “ AMINOGRAN MINERAL MIXTURE ” | 87 Clonidine Hydrochloride |
29 Amitriptyline Embonate, B.P.C. | 88 Clopamide |
30 Ammonia Aromatic Spirit, B.P.C. | 89 Clorexolone |
31 Ammonia Solution, Strong, B.P.C. | 90 Clotrimazole |
32 Ammonium Acetate Solution, Strong, B.P.C. | 91 Coal Tar, B.P.C. |
33 Ammonium Bicarbonate, B.P.C. | 92 Coconut Oil, B.P.C. |
34 Angiotensin Amide | 93 Colaspase |
35 Antazoline Sulphate | 94 Colestipol Hydrochloride |
36 Anthrax Antiserum | 95 Colophony Ointment, B.P.C. 1959 |
37 Anthrax Vaccine | 96 Copper Sulphate, B.P.C. |
38 Anti-Haemophilic Factor of Animal Origin | 97 Creosote, B.P.C. 1959 |
39 Atropine, B.P.C. | 98 Cyclothiazide |
40 Azatadine Maleate | 99 Cycrimine Hydrochloride |
41 Bacitracin, B.P. 1968 | 100 Cytarabine Hydrochloride |
42 Baclofen | 101 Danazol |
43 “ BANISH ” | 102 Daunorubicin |
44 Benserazide | 103 Death Adder Antivenom |
45 Benzalkonium Chloride | 104 Demecarium Bromide |
46 Benzoin Compound Tincture, B.P.C. | 105 Desmopressin |
47 Betamethasone Acetate | 106 Dexamethasone Metasulphobenzoate |
48 Betamethasone Dipropionate | 107 Dexchlorpheniramine Maleate |
49 Betamethasone Phosphate | 108 “ DIGESTELACT ” |
50 Bethanechol Chloride | 109 Dihydroergotamine Mesylate |
51 Biperiden Hydrochloride | 110 Dimethicone, B.P.C. |
52 Bismuth Subgallate, B.P.C. | 111 Dimethindene Maleate |
53 Black Snake Antivenom | 112 Dioctyl Sodium Sulphosuccinate, B.P.C. |
54 Bleomycin Sulphate | 113 Diphemanil Methylsulphate |
55 Brompheniramine Maleate | 114 Diphtheria and Tetanus Vaccine, Adsorbed, B.P., Diluted |
56 Brown Snake Antivenom | 115 Diphtheria Vaccine, Adsorbed, B.P., Diluted |
57 Buchu Concentrated Infusion, B.P.C. 1954 | 116 Dipyridamole |
58 Bufexamac | 117 Disopyramide |
| 118 Disopyramide Phosphate |
| 119 Doxylamine Succinate |
| 120 Droperidol |
| 121 Epicillin |
SCHEDULE 3—continued
122 Epicillin Sodium | 179 Insulin Zinc Suspension, Specially Purified Injection—Monocomponent |
123 Erythromycin Ethylsuccinate | 180 Intraperitoneal Dialysis Solutions, B.P.C. |
124 Erythromycin Gluceptate | 181 Intraperitoneal Dialysis Solutions, Concentrated |
125 Erythromycin Lactobionate | 182 Iron Polymaltose Complex |
126 Ethanolamine Oleate | 183 “ ISOMIL ” |
127 Ethoxzolamide | 184 “ KETOVITE ” Liquid |
128 Ethylnoradrenaline Hydrochloride | 185 “ KETOVITE ” Tablets |
129 Fenoterol Hydrobromide | 186 Lactulose |
130 Ferrous Aminoacetosulphate | 187 Lauryldimethylbenzyl Ammonium Chloride |
131 Ferrous Phosphate Compound, Syrup, B.P.C. 1968 | 188 Lavender Oil, Spike, B.P.C. 1968 |
132 Fluclorolone Acetonide | 189 Lead Subacetate Strong Solution, B.P.C. |
133 Flucytosine | 190 Lemon Oil Terpeneless, B.P.C. |
134 Flumethasone Pivalate | 191 Lobelia Ethereal Tincture, B.P.C. |
135 Fluorometholone | 192 “ LOCASOL ” |
136 Fluorouracil Sodium | 193 “ LOFENALAC ” |
137 Fusidic Acid | 194 Lypressin |
138 “ GALACTOMIN, FORMULA No. 17 ” | 195 Magenta, B.P.C. |
139 “ GALACTOMIN, FORMULA No. 19 ” | 196 Magnesium-Aluminium Hydroxide |
140 Gelsemium Tincture, B.P.C. | 197 Magnesium Hydroxide, B.P.C. |
141 Ginger Syrup, B.P.C. | 198 Maphenide Acetate |
142 Glucagon Hydrochloride | 199 Mebhydrolin Napadisylate, B.P.C. 1968 |
143 Glucose and Ketone Indicator | 200 Mecamylamine Hydrochloride, B.P. 1968 |
144 Glucose Indicator—Urine | 201 Medrysone |
145 “GLUCOSE NUTRAMIGEN” | 202 Mefruside |
146 Glycerophosphate Compound Syrup, A.P.F. 1964 | 203 Mercuric Chloride, B.P.C. |
147 Glymidine | 204 Methdilazine Hydrochloride |
148 Goats’ Milk, Dehydrated | 205 Methenolone Acetate |
149 Goats’ Milk, Whole (Sterilised) | 206 Methsuximide |
150 Gramicidin | 207 Methyclothiazide |
151 Guaiphenesin, B.P.C. | 208 Methylphenobarbitone, B.P.C. 1963 |
152 Haemodialysis Solutions, B.P.C. | 209 Methylprednisolone Sodium Succinate |
153 Hamamelis Liquid Extract, B.P.C. | 210 Metoprolol Tartrate |
154 Heparin Calcium | 211 Miconazole Nitrate |
155 Hexamine Hippurate | 212 Minocycline Hydrochloride |
156 Hexamine Mandelate | 213 Mithramycin |
157 Hydralazine Hydrochloride | 214 Morphine Tartrate |
158 Hydrargaphen | 215 Myrrh Tincture, B.P.C. |
159 Hydroxyurea | 216 Nalidixic Acid, B.P.C. |
160 Hyoscine Butylbromide | 217 Naphazoline Hydrochloride |
161 Hyoscyamine Sulphate | 218 Natamycin |
162 Hyoscyamus Liquid Extract, B.P.C. | 219 Neomycin Undecenoate |
163 Hypromellose 4500, B.P.C. | 220 Norgestrel |
164 Ichthammol, B.P.C. | 221 Oestradiol Valerate |
165 Influenza Vaccine—Sub Unit Type (Deoxycholate Treated) | 222 Oestrone, B.P.C. 1954 |
166 Injection of Potassium Chloride with Sodium Lactate and Anhydrous Dextrose | 223 Orange Syrup, B.P.C. |
167 Insect Allergen Extract—Bull Ant | 224 Orange Tincture, B.P.C. |
168 Insect Allergen Extract—Honey Bee | 225 Oxazepam |
169 Insect Allergen Extract—Jumper Ant | 226 Oxethazaine |
170 Insect Allergen Extract—Mosquito | 227 Oxycodone Pectinate |
171 Insect Allergen Extract—Paper Wasp | 228 Oxymel, B.P.C. |
172 Insulin Injection, Neutral Specially Purified | 229 Oxymetholone |
173 Insulin Injection Neutral, Specially Purified—Monocomponent | 230 Oxytocin |
174 Insulin Injection, Specially Purified | 231 Pancreatin Enzyme, 4 times U.S.N.F. XIII strength |
175 Insulin Injection Biphasic Specially Purified—Monocomponent | 232 Pancrelipase |
176 Insulin Isophane Injection, Specially Purified | 233 Papaveretum, B.P.C. |
177 Insulin Zinc Suspension (Amorphous), Specially Purified Injection—Monocomponent | 234 Paraffin Liquid Light, B.P.C. 1963 |
178 Insulin Zinc Suspension (Crystalline) Specially Purified Injection—Monocomponent | 235 Paramethasone Acetate |
| 236 Pectin |
| 237 Penicillinase |
| 238 Pericyazine |
| 239 Pheniramine Aminosalicylate |
| 240 Pheniramine Maleate |
| 241 Phenoxymethylpenicillin, Benzathine |
| 242 Phenoxymethylpenicillin, Hydrabamine |
| 243 Phensuximide, B.P.C. |
SCHEDULE 3—continued
244 Phenytoin, B.P.C. | 298 Sodium Gluconate |
245 Phthalylsulphacetamide | 299 Sodium Hypochlorite Solution, Strong, B.P.C. |
246 Physostigmine, B.P.C. | 300 Sodium Lactate |
247 Pindolol | 301 Sodium Nitroprusside |
248 Pituitary Hormone, Follicle-stimulating, Human | 302 Sodium Valproate |
249 Pituitary Hormone, Growth, Human | 303 Sorbide Nitrate |
250 Pituitary (Posterior Lobe) Powdered, B.P.C. | 304 “ SOYALAC ” |
251 Pizotifen Malate | 305 Spectinomycin Dihydrochloride Pentahydrate |
252 “ PK AID I ” | 306 Squill Oxymel, B.P.C. |
253 “ PK AID II ” | 307 Squill Syrup, B.P.C. |
254 Plasma Substitute (Polypeptide) | 308 Squill Tincture, B.P.C. |
255 Polyisobutylene | 309 Staphylococcus Toxoid, B.P. 1968 |
256 Polyoestradiol Phosphate | 310 Stearic Acid, B.P.C. |
257 Polyvinyl Alcohol | 311 Sterculia, B.P.C. |
258 Polyvinylpyrrolidone and Vinyl Acetate Copolymer | 312 Stilboestrol Diphosphate |
259 Potassium Chlorate, B.P.C. | 313 Stone Fish Antivenom |
260 Potassium Effervescent Tablets | 314 Stramonium Liquid Extract, B.P. 1968 |
261 Pralidoxime Iodide | 315 Sulphaphenazole, B.P.C. 1968 |
262 Prazosin Hydrochloride | 316 Sulphasalazine |
263 Prednisolone Acetate | 317 Sulphasymazine |
264 Prednisolone Steaglate | 318 Sulphurated Potash, B.P.C. |
265 Prednisolone Tertiarybutylacetate | 319 Sulphur Sublimed, B.P.C. |
266 “ PREGESTIMIL ” | 320 Surgical Cement |
267 Procarbazine Hydrochloride | 321 Surgical Cement Solvent |
268 Prochlorperazine | 322 Tacrine |
269 Prochlorperazine Edisylate | 323 Taipan Antivenom |
270 Proflavine Hemisulphate, B.P.C. | 324 Tamoxifen Citrate |
271 Proscillaridin | 325 Tartrazine, B.P.C. 1954 |
272 “ PROSOBEE ” | 326 Terbutaline Sulphate |
273 Pumilio Pine Oil, B.P.C. | 327 “ TERIC N8 ” |
274 Pyrantel Embonate | 328 Testosterone Decanoate |
275 Quillaia Tincture, B.P.C. | 329 Testosterone Enanthate |
276 Quinethazone | 330 Testosterone Isocaproate |
277 Quinidine Bisulphate | 331 Tetracycline, B.P.C. |
278 Rabies Immune Globulin, Human | 332 Thiethylperazine Malate |
279 Rabies Vaccine (Duck Type) | 333 Thiethylperazine Maleate |
280 Rabies Vaccine Inactivated (Human Type) | 334 Thioguanine |
281 Raspberry Syrup, B.P.C. | 335 Thiopropazate Hydrochloride, B.P.C. |
282 Rauwolfia Alkaloids | 336 Tiger Snake Antivenom |
283 Rauwolfia Serpentina, B.P.C. | 337 Timolol Maleate |
284 Red Back Spider Antivenom | 338 Tinidazole |
285 Rolitetracycline | 339 Titanium Dioxide, B.P.C. |
286 Rosemary Oil, B.P.C. | 340 Tobramycin Sulphate |
287 Saccharin Tablets, B.P.C. | 341 Tolazamide |
288 Salicylamide | 342 Tolu Syrup, B.P.C. |
289 Sea Wasp Antivenom | 343 Triethanolamine, B.P.C. |
290 Secbutobarbitone Sodium | 344 Triglycerides Oil, Medium Chain |
291 Senega, Concentrated Infusion, B.P.C. | 345 “ TRIGLYDE ” |
292 Siberian Fir Oil, B.P.C. 1949 | 346 Trimetaphan Camsylate, B.P. 1968 |
293 Silver Protein, B.P.C. 1968 | 347 Trioxysalen |
294 Silver Protein Mild, B.P.C. 1968 | 348 Vasopressin Tanhate |
295 Snake Bite Antivenom—Polyvalent | 349 Verapamil Hydrochloride |
296 Sodium Carboxymethylcellulose | 350 “ ZERODOR ” |
297 Sodium Citro-Tartrate | 351 “ ZOFF ” |
SCHEDULE 4 Regulation 12 and
sub-regulation 35 (1)
ADDITIVES
1 Acetone, B.P.C. | 18 Ether, Anaesthetic, B.P. |
2 Alcohol (95%), B.P. | 19 Ether, Solvent, B.P. |
3 Arachis Oil, B.P. | 20 Eucalyptus Oil, B.P. |
4 Boric Acid, B.P. | 21 Honey, Purified, B.P.C. |
5 Camphor, B.P. | 22 Hypromellose 4500, B.P.C. |
6 Caramel Solution, A.P.F. | 23 Industrial Methylated Spirit, B.P. |
7 Castor Oil, B.P. | 24 Linseed Oil |
8 Chlorhexidine Acetate, B.P.C. | 25 Maize Oil, B.P. |
9 Chlorhexidine Gluconate Solution, B.P. | 26 Methylcellulose 20, B.P.C. |
10 Chloroform, B.P. | 27 Methylcellulose 4500, B.P.C. |
11 Cineole, B.P.C. | 28 Olive Oil, B.P. |
12 Citronella Oil, B.P.C. | 29 Peppermint Oil, B.P. |
13 Concentrated Anise Water, B.P.C. | 30 Saccharin Sodium, B.P. |
14 Concentrated Cinnamon Water, B.P.C. | 31 Sodium Thiosulphate, B.P. |
15 Concentrated Peppermint Water, B.P. | 32 Syrup of Pholcodine Citrate, B.P.C. 1959 |
16 Dextrose, B.P. | 33 Turpentine Oil, B.P. |
17 Dilute Alcohols, B.P. | 34 Xylene, B.P.C. 1949 |
SCHEDULE 5 Sub-regulations 14 (1), (2) and (5),
paragraphs 19 (1) (h) and 21 (1)
(e) and sub-regulation 22 (2)
PHARMACEUTICAL BENEFITS THE PRESCRIBING OF WHICH IS SUBJECT TO CONDITIONS AND RESTRICTIONS
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
1 | Acetylcysteine................ | Bronchiectasis |
|
| Cystic fibrosis (mucoviscidosis) |
2 | Acrylic Resin................. | Ileostomy or colostomy conditions |
3 | “ ALBUMAID XP ”............ | Phenylketonuria |
4 | Alginic Acid Compound Powder | With the written authority of the Permanent Head, cardio-oesophageal reflux |
5 | Alginic Acid Compound Granules | With the written authority of the Permanent Head, cardio-oesophageal reflux not responding to antacid therapy |
6 | Alprenolol Injection, B.P......... | Dissecting aneurysm (aortic) |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
|
| Thyrotoxicosis |
7 | Alprenolol Tablets, B.P.......... | Dissecting aneurysm (aortic) |
|
| Hypertension |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
|
| Thyrotoxicosis |
8 | Amantadine Hydrochloride........ | The treatment of Parkinson’s disease caused otherwise than by treatment with a drug |
9 | (1) Aminocaproic Acid, B.P. | Treatment in hospital of patients suffering from severe haemorrhage associated with excessive fibrinolysis |
| (2) Aminocaproic Acid Injection, B.P. | |
10 | “AMINOGRAN FOOD SUPPLEMENT” | Phenylketonuria |
11 | “AMINOGRAN MINERAL MIXTURE” | Phenylketonuria |
12 | Ascorbic Acid Tablets, B.P. | Any disease or condition in a pensioner |
13 | Azathioprine Tablets, B.P......... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Permanant Head— |
|
| Anaemia, autoimmune haemolytic |
|
| Arthritis, rheumatoid with vasculitis or visceral complications |
|
| Continuing azathioprine therapy after discharge from an approved hospital |
SCHEDULE 5—continued
Column 1 Column 2 | Column 3 | |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
|
| Crohn’s disease |
|
| Dermatomyositis |
|
| Granulomatosis, Wegener’s |
|
| Hepatitis, active, chronic |
|
| Lupus erythematosus, systemic |
|
| Nephritis |
|
| Nephrotic syndrome |
|
| Organ transplant |
|
| Pemphigus vulgaris |
|
| Polyarteritis nodosa |
|
| Pyoderma gangrenosum |
|
| Scleroderma |
|
| Thrombocytopenic purpura |
|
| Ulcerative colitis |
14 | Baclofen................... | With the written authority of the Permanent Head, spasticity due to multiple sclerosis or spinal cord lesions |
15 | “ BANISH ” | Ileostomy or colostomy conditions |
16 | Beclomethasone Dipropionate Metered Aerosol Spray | Chronic intractable asthma requiring maintenance corticosteroids |
17 | Benzoin Compound Tincture, B.P.C., Aerosol Spray | Ileostomy or colostomy conditions |
18 | Betamethasone Acetate with Betamethasone Injection | Alopecia areata |
| Granulomata, dermal | |
|
| Keloid |
|
| Lichen planus hypertrophic |
|
| Lichen simplex chronicus |
|
| Local intra-articular or peri-articular infiltration |
|
| Lupus erythematosus, chronic discoid |
|
| Necrobiosis lipoidica |
|
| Uveitis |
19 | Bisacodyl Suppositories, B.P. | Any disease or condition in a paraplegic or quadriplegic patient |
|
| For use by patients who are receiving long-term intensive nursing care in hospitals or nursing homes |
20 | Bleomycin Sulphate............ | Choriocarcinoma of the testis |
|
| Embryonal cell carcinoma of the testis |
|
| Lymphoma |
|
| Squamous cell carcinoma |
21 | (1) Calciferol, B.P............. | With the written authority of the Permanent Head— |
| (2) Calciferol Tablets, Strong, B.P. | Hypocalcemia |
| Hypoparathyroidism | |
|
| Osteomalacia following gastrectomy, severe steatorrhoea or renal failure |
|
| Vitamin D-resistant rickets |
22 | Calcium Carbonate, B.P., with Calcium Lactate-Gluconate | With the written authority of the Permanent Head— |
| Hypocalcaemia | |
|
| Osteoporosis |
23 | Calcium Carbonate, B.P., with Citric Acid Monohydrate, B.P., Compound Effervescent Tablets | With the written authority of the Permanent Head— |
| Hypocalcaemia | |
| Osteoporosis | |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
24 | Calcium Folinate.............. | Antidote to folic acid antagonists |
25 | Carbenicillin Sodium........... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Permanent Head— |
|
| Infections where positive bacteriological evidence confirms that carbenicillin is the most appropriate therapeutic agent |
|
| Septicaemia, suspected or proven |
26 | Carbenoxolone Tablets, B.P....... | Gastric ulcer where a radiological examination or other tests have confirmed the presence of a gastric ulcer |
27 | (1) Cephalexin Capsules, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Cephalexin Tablets, B.P....... | |
| (3) Cephalexin, B.P., with Purified Water, B.P. | With the written authority of the Permanent Head, infections where positive bacteriological evidence confirms that cephalexin monohydrate is the most appropriate therapeutic agent |
28 | Cephaloridine ................ | Endophthalmitis |
|
| Infections where positive bacteriological evidence confirms that cephaloridine is the most appropriate therapeutic agent |
29 | Cephalothin Sodium............ | Infections where positive bacteriological evidence confirms that cephalothin sodium is the most appropriate therapeutic agent |
30 | Cephazolin Sodium............ | Infections where positive bacteriological evidence confirms that cephazolin sodium is the most appropriate therapeutic agent |
31 | (1) Cephradine Capsules......... | With the written authority of the Permanent Head, infections where positive bacteriological evidence confirms that cephradine is the most appropriate therapeutic agent |
| (2) Cephradine with Purified Water, B.P. | |
32 | Cephradine for Injection......... | Infections where positive bacteriological evidence confirms that cephradine is the most appropriate therapeutic agent |
33 | Charcoal Tablets.............. | Ileostomy or colostomy conditions |
34 | Chlorambucil Tablets, B.P........ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Permanent Head— |
|
| Anaemia, autoimmune, haemolytic |
|
| Arthritis, rheumatoid with vasculitis or visceral complications |
|
| Continuing chlorambucil therapy after discharge from an approved hospital |
|
| Crohn’s disease |
|
| Dermatomyositis |
|
| Granulomatosis, Wegener’s |
|
| Hepatitis, active chronic |
|
| Lupus erythematosus, systemic |
|
| Malignant disease including leukaemia |
|
| Nephritis |
|
| Nephrotic syndrome |
|
| Polyarteritis nodosa |
|
| Scleroderma |
|
| Thrombocytopenic purpura |
|
| Ulcerative colitis |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
35 | Chloramine Deodorant Tablets and Powder | Ileostomy or colostomy conditions |
36 | (1) Chloramphenicol Capsules, B.P. | Bacterial meningitis |
| Intraocular infections | |
| (2) Chloramphenicol Sodium Succinate for Injection | Rickettsioses |
| Typhoid | |
| (3) Chloramphenicol Palmitate Oral Suspension | The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient |
37 | (1) Chlormethiazole.......... | For short term use in a hospital for alcohol or drug withdrawal therapy |
| (2) Chlormethiazole Edisylate | Status epilepticus |
38 | Chlorotrianisene Tablets...... | Carcinoma of the prostate |
39 | (1) Chlorpromazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Chlorpromazine Injection, B.P. | Chorea |
| Hyperactive states of organic or toxic delirium | |
| (3) Chlorpromazine Tablets, B.P. | Major psychoses including— |
| Major organic psychoses including arteriopathic dementia | |
|
| Manic-depressive psychosis |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients who have not attained the age of 16 years |
40 | Cholestyramine........... | With the written authority of the Permanent Head— |
|
| Bile salt malabsorption associated with ileal resection or proven ileal disease |
|
| Pruritus associated with partial biliary obstruction not responding to other therapy |
|
| Treatment of hypercholesterolemia |
41 | Cimetidine............... | With the written authority of the Permanent Head— |
|
| Peptic ulcer, proven by radiology or endoscopy Zollinger-Ellison syndrome, proven by investigation |
42 | (1) Clindamycin Hydrochloride | Gram-positive coccal infections where the infection cannot be safely and effectively treated with penicillin or a derivative of penicillin |
| (2) Clindamycin Palmitate Hydrochloride | |
43 | Clofibrate Capsules, B.P...... | With the written authority of the Permanent Head— |
|
| Diabetic retinopathy (exudative) |
|
| Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy |
|
| A second or subsequent course of treatment of hyperlipidaemia where significant lowering of serum triglyceride or serum cholesterol subsequent to initial treatment with clofibrate has been established by laboratory report |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
44 | Clonazepam.............. | Epilepsy |
45 | Clotrimazole Cream ……………. | Cutaneous candidiasis |
|
| Dermatomycosis |
|
| Pityriasis versicolor |
46 | (1) Cloxacillin Capsules, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Cloxacillin Sodium, B.P., with Purified Water, B.P. | |
| With the written authority of the Permanent Head— | |
|
| Infections due to the presence of penicillin-resistant staphylococci |
|
| Osteomyelitis |
47 | (1) Codeine Phosphate with Aspirin, Soluble Tablets | Any disease or condition in a pensioner |
| (2) Codeine Phosphate with Aspirin and Paracetamol Tablets, 8mg-250mg-250mg tablets |
|
48 | Codeine Phosphate with Aspirin and Paracetamol Tablets, 30mg-225mg-150mg tablets | Malignant neoplasia |
49 | Colestipol Hydrochloride .. | With the written authority of the Permanent Head, treatment of hypercholesterolaemia |
50 | Colistin Sulphomethate Sodium, B.P., for injection | Pyocyaneus infection, other gram-negative infections where no other drug is effective |
51 | Cyanocobalamin Injection, B.P. | Neuroblastoma |
| Pernicious anaemia and other proven Vitamin B12 deficiencies | |
|
| Post-gastrectomy treatment |
|
| Sub-acute combined degeneration of the cord |
52 | (1) Cyclophosphamide, B.P. .. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Cyclophosphamide Tablets, B.P. | |
| With the written authority of the Permanent Head— | |
|
| Anaemia, autoimmune, haemolytic |
|
| Arthritis, rheumatoid with vasculitis or visceral complications |
|
| Continuing cyclophosphamide therapy after discharge from an approved hospital |
|
| Crohn’s disease |
|
| Dermatomyositis |
|
| Granulomatosis, Wegener’s |
|
| Hepatitis, active, chronic |
|
| Lupus erythematosus, systemic |
|
| Malignant disease, including leukaemia |
|
| Nephritis |
|
| Nephrotic syndrome |
|
| Pemphigus vulgaris |
|
| Polyarteritis nodosa |
|
| Scleroderma |
|
| Thrombocytopenic purpura |
|
| Ulcerative colitis |
53 | Danazol | With the written authority of the Permanent Head— |
|
| endometriosis proven by laparoscopy or laparotomy |
54 | Deodorant Detergent Solution (Lauryldimethylbenzyl Ammonium Chloride and “ TERIC N8 ”) | Any disease or condition in a paraplegic or quadriplegic patient |
| Ileostomy or colostomy conditions |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
55 | Dexamethasone Sodium Phosphate Injection equivalent of Dexamethasone Phosphate 120 mg in 5 ml | For use in a hospital |
56 | Dexamphetamine Tablets, B.P. | With the written authority of the Permanent Head— |
| For the treatment of a patient who has not attained the age of 21 years and who is hyperkinetic as a result of brain damage | |
|
| Narcolepsy |
57 | (1) Dextromoramide Tablets, B.P. | Treatment in malignant neoplasia |
| (2) Dextromoramide Tartrate, B.P. |
|
58 | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride | Vomiting in pregnancy |
59 | “ DIGESTELACT ”.......... | With the written authority of the Permanent Head, lactose intolerance |
60 | Dihydrotachysterol.......... | With the written authority of the Permanent Head— |
|
| Hypoparathyroidism |
|
| Osteomalacia following gastrectomy, severe steatorrhoea or renal failure |
|
| Vitamin D-resistant rickets |
61 | Dimethicone Aerosol Spray..... | Ileostomy or colostomy conditions |
62 | Dimethicone Creams......... | Any disease or condition in a paraplegic or quadriplegic patient |
|
| Use with surgical appliances |
63 | (1) Dioctyl Sodium Sulphosuccinate | Any disease or condition in a paraplegic or quadriplegic patient |
| (2) Dioctyl Sodium Sulphosuccinate with Bisacodyl | For use in patients who are receiving long-term intensive nursing care in hospitals or nursing homes |
| (3) Dioctyl Sodium Sulphosuccinate with Danthron |
|
64 | Diphemanil Methylsulphate | Amputees |
|
| Any disease or condition in a paraplegic or quadriplegic patient |
65 | Dipyridamole .. .. | Supplementing anticoagulants in— |
|
| Biopsy proven glomerulonephritis |
|
| Microangiopathic renal disease |
|
| Renal allograft |
|
| Patients with cardiac prosthesis |
66 | (1) Disopyramide .. | With the written authority of the Permanent Head, cardiac arrhythmias, only when other anti-arrhythmic drug therapy is unsatisfactory |
| (2) Disopyramide Phosphate | |
67 | Droperidol................ | Any disease or condition in a patient receiving treatment in a hospital |
68 | Ethacrynic Acid Tablets, B.P. | Patients who are hypersensitive to other oral diuretics |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
69 | Ethyloestrenol Tablets, B.P.... | With the written authority of the Permanent Head— |
|
| Osteoporosis |
|
| Patients on long-term treatment with corticosteroids |
70 | Flucytosine............... | Invasive or systemic fungal infections such as candidiasis, cryptococcosis and chromoblastomycosis |
71 | Fluoxymesterone Tablets, B.P. | With the written authority of the Permanent Head— |
|
| Aplastic anaemias, proven |
|
| Carcinoma of the breast |
|
| Hypogonadism |
|
| Osteoporosis |
72 | (1) Fluphenazine Decanoate Injection, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Fluphenazine Enanthate Injection, B.P. | Chorea |
| Hyperactive states of organic or toxic delirium | |
| (3) Fluphenazine Hydrochloride, B.P. | Major psychoses including— |
| Major organic psychoses including arteriopathic dementia | |
| (4) Fluphenazine Tablets, B.P. | |
|
| Manic-depressive psychosis |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
73 | (1) Folic Acid, B.P.......... | Cystic fibrosis |
| (2) Folic Acid Tablets, B.P., 5 mg | Haemolytic anaemia, chronic |
| Proven folic acid deficiency | |
|
| Sprue or the sprue-like syndrome |
74 | Frusemide Tablets, B.P., 500 mg | Renal failure |
75 | Fusidic Acid.............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Permanent Head, for use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence |
76 | “ GALACTOMIN FORMULA No. 17 ” | With the written authority of the Permanent Head— |
| Galactosaemia | |
|
| Conditions needing an extreme restriction of lactose in the diet of a patient who has not attained the age of 4 years |
76A | “ GALACTOMIN FORMULA No. 19 ” | With the written authority of the Permanent Head— |
| glucose-galactose malabsorption | |
77 | Gentamicin Injection, B.P..... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| Endophthalmitis |
|
| With the written authority of the Permanent Head— |
|
| Infections where positive bacteriological evidence confirms that gentamicin sulphate is the most appropriate antibiotic |
|
| Septicaemia including suspected septicaemia |
78 | “ GLUCOSE NUTRAMIGEN ” | With the written authority of the Permanent Head— |
| Cows’ milk allergy in children who have not attained the age of 2 years |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed for supply under Part VII of the Act |
|
| Cystic fibrosis (mucoviscidosis) |
|
| Galactosaemia |
|
| Lactose intolerance |
79 | Glycerol Suppositories, B.P.... | Any disease or condition in a paraplegic or quadriplegic patient |
|
| For use by patients who are receiving long-term intensive nursing care in hospitals or nursing homes |
80 | Goats’ Milk, dehydrated...... | With the written authority of the Permanent Head’ cows’ milk allergy in children who have not attained the age of 2 years |
81 | Goats’ Milk, Whole (sterilized) | With the written authority of the Permanent Head, cows’ milk allergy in children who have not attained the age of 2 years |
82 | Griscofulvin Tablets, B.P..... | With the written authority of the Permanent Head— |
|
| For use in recalcitrant tinea infections due to Microsporum, Trichophyton or Epidermophyton species proven by pathology testing, or, in the case of the scalp, by pathology testing or by Wood’s Light examination Kerion |
83 | (1) Haloperidol............ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Haloperidol Tablets, B.P., 1.5 mg | |
| Chorea | |
|
| Hyperactive states of organic or toxic delirium |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Major psychoses including— |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic-depressive psychosis |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
84 | Haloperidol Tablets, B.P., 5 mg | For use in a hospital for acute schizophrenia or mania |
85 | (1) Hydrochlorothiazide, B.P., with Amiloride Hydrochloride | Cardiac failure |
| (2) Hydrochlorothiazide, B.P., with Triamterene, B.P. |
|
86 | Hydrocortisone Acetate Injection, B.P. | Alopecia areata |
| Granulomata, dermal | |
|
| Keloid |
|
| Lichen planus hypertrophic |
|
| Lichen simplex chronicus |
|
| Local intra-articular or peri-articular infiltration |
|
| Lupus erythematosus, chronic discoid |
87 | Hydrocortisone Sodium Succinate Injection, 500 mg | Any disease or condition in a patient receiving treatment in a hospital |
88 | Hydroxocobalamin Injection, B.P. | Neuroblastoma |
| Pernicious anaemia and other proven Vitamin B12 deficiencies | |
|
| Post-gastrectomy treatment |
|
| Sub-acute combined degeneration of the cord |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
89 | Ibuprofen Tablets.......... | Osteoarthritis where salicylates are contra-indicated or ineffective |
|
| Rheumatoid arthritis where salicylates are contra-indicated or ineffective |
90 | (1) Idoxuridine Eye Drops..... | Infections caused by Herpes Simplex Virus or by Vaccinia Virus |
| (2) Idoxuridine Eye Ointment | |
91 | Influenza Vaccine.......... | For prophylaxis of— |
|
| pensioners |
|
| persons suffering from any severe debilitating disease, chronic heart disease or chronic pulmonary disease |
92 | (1) Insulin Injection Biphasic Specially Purified—Monocomponent | Insulin resistance, insulin allergy, disabling local reactions or atrophy |
| Juvenile diabetes | |
| (2) Insulin Injection, Neutral Specially Purified |
|
| (3) Insulin Injection, Neutral Specially Purified—Monocomponent |
|
| (4) Insulin Isophane Injection Specially Purified—Porcine |
|
| (5) Insulin Zinc Suspension Specially Purified Injection—Monocomponent |
|
| (6) Insulin Zinc Suspension (Amorphous) Specially Purified Injection—Monocomponent |
|
| (7) Insulin Zinc Suspension (Crystalline) Specially Purified Injection—Monocomponent |
|
93 | “ ISOMIL ”.............. | With the written authority of the Permanent Head— |
|
| Cows’ milk allergy in children who have not attained the age of 2 years |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
94 | Kanamycin Injection, B.P..... | Infections where positive bacteriological evidence confirms that kanamycin sulphate is the most appropriate antibiotic |
|
| Septicaemia, including suspected septicaemia |
95 | (1) “ KETOVITE ” Liquid..... | With the written authority of the Permanent Head— |
| (2) “ KETOVITE ” Tablets.... | Galactosaemia |
|
| Persistent monosaccharide intolerance |
|
| Phenylketonuria |
|
| Tyrosinosis (hereditary) |
96 | Lactulose................ | Hepatic coma or pre-coma (chronic portosystemic encephalopathy) |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
97 | (1) Levodopa, B.P., with Benserazide | Treatment of Parkinson’s Disease |
| (2) Levodopa, B.P., with Carbidopa |
|
| (3) Levodopa Capsules, B.P. |
|
| (4) Levodopa Tablets, B.P. |
|
98 | Lincomycin Injection, B.P. .. | Gram-negative anaerobic infections |
|
| Gram-positive coccal infections where these cannot be safely and effectively treated with penicillin or a derivative of penicillin |
99 | Lithium Carbonate Tablets, B.P. | Manic depression |
100 | “ LOCASOL ”............ | With the written authority of the Permanent Head— |
|
| Hypercalcaemia in children who have not attained the age of 2 years |
|
| Osteopetrosis |
101 | “ LOFENALAC ”.......... | Phenylketonuria |
102 | Maphenide Acetate......... | With the written authority of the Permanent Head, treatment, in a hospital of burns |
103 | (1) Medroxyprogesterone Acetate Injections, 50 mg in 1 ml | Malignant neoplasia |
| Precocious puberty | |
| (2) Medroxyprogesterone Acetate Injections, 150 mg in 1 ml |
|
104 | Medroxyprogesterone Acetate Tablets, 2.5 mg | Precocious puberty |
| Turner’s syndrome | |
105 | Medroxyprogesterone Acetate Tablets, 10 mg | Malignant neoplasia |
| Precocious puberty | |
|
| Turner’s syndrome |
106 | Medroxyprogesterone Acetate Tablets, 100 mg | Malignant neoplasia |
107 | (1) Metformin Hydrochloride, B.P. | Maturity onset diabetes in patients under 65 years of age not satisfactorily controlled by diet and other drugs and in whom the risk of lactic acidosis is negligible |
| (2) Metformin Tablets, B.P. | |
108 | (1) Methadone Injection, B.P. | Disabling pain associated with malignant neoplasia or self-limiting disorders of short duration where the patient has not responded to non-narcotic analgesics |
| (2) Methadone Tablets, B.P. | |
109 | (1) Methandienone Tablets, B.P. | With the written authority of the Permanent Head— |
| Osteoporosis | |
| (2) Methenolone Acetate .. | Patients on long-term treatment with corticosteroids |
110 | Methicillin Sodium, B.P., for injection | Endophthalmitis |
| Proven or suspected staphylococcal septicaemia | |
111 | (1) Methotrexate Injection .. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Methotrexate Tablets .. |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
|
| With the written authority of the Permanent Head— |
|
| Continuing methotrexate therapy after discharge from an approved hospital |
|
| Malignant neoplasia |
|
| Pemphigus vulgaris |
|
| Severe intractable or extensive psoriasis |
112 | Methylphenobarbitone....... | Epilepsy |
113 | Methylprednisolone Acetate Injection | For local intra-articular or peri-articular infiltration |
114 | Methylprednisolone Acetate Retention Enema | Proctitis |
| Ulcerative colitis | |
115 | Methyltestosterone Tablets, B.P., 5 mg | Hypogonadism in patients who have not attained the age of 16 years |
116 | (1) Methyltestosterone, B.P. | Carcinoma of the breast |
| (2) Methyltestosterone Tablets, B.P., 25 mg or 50 mg | Hypogonadism |
| Klinefelter’s syndrome (seminiferous tubule dysgenesis) | |
117 | Methysergide Tablets........ | Carcinoid syndrome |
|
| Prevention of disabling migraine when other treatment has failed |
118 | Metoclopramide Hydrochloride 10 mg Tablets | For use in a hospital for chronic gastric retention after gastric surgery |
119 | Metoprolol Tartate.......... | Frequent disabling angina without evidence of cardiac failure |
|
| Hypertension |
120 | Miconazole Nitrate......... | Cutaneous candidiasis |
|
| Dermatomycosis |
|
| Pityriasis versicolor |
121 | Mithramycin.............. | For use in a hospital for— |
|
| Inoperable testicular neoplasm |
|
| Symptomatic hypercalcaemia and hypercalcinuria associated with advanced neoplasia |
122 | Morphine Sulphate, B.P., with Tacrine, Tablets | Severe intractable pain |
123 | Nalidixic Acid............ | Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to nalidixic acid or where the patient is sensitive to sulphonamides |
124 | Nandrolone Decanoate Injection, B.P. | With the written authority of the Permanent Head— |
| Carcinoma of the breast | |
|
| Osteoporosis |
|
| Patients on long-term treatment with corticosteroids |
125 | Nandrolone Phenylpropionate Injection, B.P. | With the written authority of the Permanent Head— |
| Carcinoma of the breast | |
|
| Osteoporosis |
|
| Patients on long-term treatment with corticosteroids |
126 | Neomycin Tablets, B.P. .. | Acute leukaemia during induction of remission with chemotherapy |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
|
|
Bowel sterilisation preparatory to major surgery |
|
| Encephalopathy, hepatic |
|
| Enteropathogenic E. coli infections in infants |
127 | Nicotinic Acid Tablets, B.P.... | Any disease or condition in a pensioner |
128 | (1) Nitrofurantoin, B.P....... | Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to nitrofurantoin, or where the patient is sensitive to sulphonamides |
| (2) Nitrofurantoin Tablets, B.P. | |
129 | Norethisterone Acetate, B.P., Tablets, 10 mg | Carcinoma of the breast |
| Carcinoma of the endometrium | |
130 | Norethisterone Acetate, B.P., Tablets, 2.5 mg | Endometriosis |
| Metropathia haemorrhagica | |
|
| Precocious puberty |
|
| Turner’s syndrome |
131 | Norethisterone Tablets, B.P., 5 mg | Benign mammary dysplasia |
| Endometriosis | |
|
| Metropathia haemorrhagica |
|
| Precocious puberty |
|
| Turner’s syndrome |
132 | Orphenadrine Hydrochloride Tablets, B.P. | Parkinsonism |
133 | Oxprenolol Hydrochloride, B.P., Injection | Idiopathic hypertrophic subaortic stenosis |
| Right ventricular outflow tract obstruction | |
|
| Dissecting aneurysm (aortic) |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
134 | Oxprenolol Tablets, B.P...... | Dissecting aneurysm (aortic) |
|
| Hypertension |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
|
| Thyrotoxicosis |
135 | Oxycodone Pectinate........ | Treatment in malignant neoplasia |
136 | Oxymetholone............ | With the written authority of the Permanent Head— |
|
| Proven aplastic anaemias |
|
| Myelosclerosis |
137 | (1) Pancreatin, B.P. .. | Cystic fibrosis (mucoviscidosis) |
| (2) Pancreatin Enzyme 4X U.S.N.F. XIII strength | Following pancreatico-duodenectomy |
| Pancreatic steatorrhoea | |
| (3) Pancrelipase |
|
138 | (1) Penicillamine Capsules, B.P. | With the written authority of the Permanent Head— |
| Acute heavy metal intoxication | |
| (2) Penicillamine, B.P., Tablets | Cystinosis |
|
| Cystinuria with calculus formation |
|
| Haemoglobinuria, paroxysmal cold |
|
| Wilson’s disease (hepatolenticular degeneration) |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
139 | Pentazocine Lactate Injection, B.P. | Disabling pain associated with malignant neoplasia or self-limiting disorders of short duration which fail to respond to non-narcotic analgesics |
140 | Pericyazine............... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| Chorea |
|
| Hyperactive states of organic or toxic delirium |
|
| Major psychoses, including— |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic-depressive psychosis |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients who have not attained the age of 16 years |
141 | Phenelzine Tablets, B.P...... | Depressive illness resistant to treatment with tricyclic antidepressants or electroconvulsive therapy |
|
| Phobic states |
142 | Phenobarbitone Tablets, B.P. | Epilepsy |
143 | Pindolol Injection.......... | Dissecting aneurysm (aortic) |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
|
| Thyrotoxicosis |
144 | Pindolol Tablets .. .. | Dissecting aneurysm (aortic) |
|
| Hypertension |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence or cardiac failure is found |
|
| Thyrotoxicosis |
145 | Pizotifen Malate........... | Prevention of migraine |
146 | (1) “ PK AID I ”........... | Phenylketonuria |
| (2) “ PK AID II ” |
|
147 | Polyisobutylene............ | Ileostomy or colostomy conditions |
148 | Polyoestradiol Phosphate..... | Carcinoma of the breast |
|
| Carcinoma of the prostate |
149 | Polyvinylpyrrolidone and Vinyl Acetate Copolymer | Ileostomy or colostomy conditions |
|
| |
150 | Prazosin Hydrochloride...... | Refractory hypertension |
151 | (1) Prednisolone Acetate Injection | Local intra-articular or peri-articular infiltration |
| (2) Prednisolone Tertiarybutylacetate Injection |
|
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
152 | Prednisolone Acetate with Phenylephrine Hydrochloride, B.P. | Corneal grafts |
| Uveitis | |
153 | Prednisolone Sodium Phosphate Retention Enema and Suppository | Ulcerative colitis |
| Proctitis | |
154 | “ PREGESTIMIL ”......... | With the written authority of the Permanent Head— |
|
| Cystic fibrosis |
|
| Multiple disaccharidase deficiency |
155 | Propantheline Tablets, B.P. | With the written authority of the Permanent Head, chronic neurogenic incontinence of urine |
156 | Propranolol Injection, B.P..... | Dissecting aneurysm (aortic) |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
|
| Thyrotoxicosis |
157 | (1) Propranolol Tablets, B.P., 10 mg and 40 mg | Benign essential tremor (not Parkinsonian tremor) |
| Dissecting aneurysm (aortic) | |
|
| Hypertension |
|
| Idiopathic hypertrophic subaortic stenosis. |
|
| Prevention of migraine |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
|
| Thyrotoxicosis |
| (2) Propranolol Tablets, B.P., 160 mg | With the written authority of the Permanent Head— |
| Hypertension where there is an inadequate response to a daily dose of at least 160 mg of propranolol | |
|
| Frequent disabling angina without evidence of cardiac failure where there is an inadequate response to a daily dose of at least 160 mg of propranolol |
158 | “ PROSOBEE ”........... | With the written authority of the Permanent Head— |
|
| Cows’ milk allergy in children who have not attained the age of 2 years |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
159 | Pyridoxine Hydrochloride Tablets | Anaemia proved to be responsive to pyridoxine |
| Convulsions responsive to pyridoxine | |
|
| Homocystinuria |
|
| Primary hyperoxaluria |
|
| Radiation sickness |
|
| Sideroblastic (refractory) anaemia |
|
| Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy |
160 | Riboflavine Tablets......... | Any disease or condition in a pensioner |
161 | Sodium Carboxymethylcellulose with Pectin and Gelatin | Ileostomy or colostomy conditions |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
162 | Sodium Cromoglycate, B.P. | With the written authority of the Permanent Head, allergic rhinitis not responding to other treatment |
163 | Sodium Fusidate........... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Permanent Head, for use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence |
164 | Sodium Nitroprusside........ | For use in a hospital |
165 | Sodium Valproate.......... | Epilepsy |
166 | “ SOYALAC ”............ | With the written authority of the Permanent Head— |
|
| Cows’ milk allergy in children who have not attained the age of 2 years |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
167 | Spironolactone Tablets, B.P. | To supplement other diuretics when these have proved inadequate |
|
| Myasthenia gravis |
|
| Primary hyperaldosteronism |
|
| Secondary hyperaldosteronism |
168 | Sterculia................ | Ileostomy or colostomy conditions |
169 | Stilboestrol Diphosphate...... | Carcinoma of the prostate |
170 | Streptokinase, B.P.......... | Any disease or condition in a patient receiving treatment in a hospital |
171 | (1) Surgical Cement......... | Any disease or condition in a paraplegic or quadriplegic patient |
| (2) Surgical Cement Solvent... | |
|
| For use with surgical appliances |
|
| Ileostomy or colostomy conditions |
172 | (1) Testosterone Enanthate.... | Carcinoma of the breast |
| (2) Testosterone Propionate Injection, B.P. | Hypogonadism |
|
| Klinefelter’s syndrome (seminiferous tubule dysgenesis) |
173 | (1) Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate | Carcinoma of the breast |
| Gigantism | |
| Hypogonadism | |
| Klinefelter’s syndrome (seminiferous tubule dysgenesis) | |
| (2) Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
|
174 | Tetracosactrin Acetate, B.P. | With the written authority of the Permanent Head— |
|
| Hypsarrhythmia |
|
| Multiple sclerosis, acute exacerbation |
|
| Status asthmaticus |
|
| Treatment of children who need long-term corticosteriod |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed for supply under Part VII, of the Act |
|
| therapy but who are in danger of growth suppression as a result |
|
| Treatment of patients who are being withdrawn from long-term corticosteroid therapy |
|
| Ulcerative colitis, proven, not responding to parenteral corticosteroids |
175 | Tetracosactrin Zinc Injection, B.P. | With the written authority of the Permanent Head— |
| Hypsarrhythmia | |
|
| Multiple sclerosis, acute exacerbation |
|
| Status asthmaticus |
|
| Treatment of children who need long-term corticosteroid therapy but who are in danger of growth suppression as a result |
|
| Treatment of patients who are being withdrawn from long-term corticosteroid therapy |
|
| Ulcerative colitis, proven, not responding to parenteral corticosteroids |
176 | Thiamine Hydrochloride Tablets, B.P. | Any disease or condition in a pensioner |
177 | Thioguanine................ | Leukaemia |
178 | Thiopropazate Hydrochloride | Chorea |
|
| Drug induced dystonias |
179 | (1) Thioridazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment |
| in or at an approved hospital | |
| (2) Thioridazine Tablets, B.P. | Chorea |
|
| Hyperactive states of organic or toxic delirium |
|
| Major psychoses including— |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic-depressive psychosis |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients who have not attained the age of 16 years |
180 | Timolol Maleate............. | Dissecting aneurysm (aortic) |
|
| Frequent disabling angina without evidence of cardiac failure |
|
| Hypertension |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
181 | Tobramycin Sulphate.......... | With the written authority of the Permanent Head— |
|
| Infections where positive bacteriological evidence confirms that tobramycin sulphate is the most appropriate antibiotic |
|
| Septicaemia, suspected or proven |
182 | Tranylcypromine Tablets, B.P. | Depressive illness resistant to treatment with tricyclic antidepressants or electroconvulsive therapy |
|
| Phobic states |
183 | Triamcinolone Acetonide Injection | Alopecia areata |
| Granulomata, dermal | |
|
| Keloid |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed for supply under Part VII, of the Act |
|
| Lichen planus hypertrophic |
|
| Lichen simplex chronicus |
|
| Lupus erythematosus, chronic discoid |
|
| Necrobiosis lipoidica |
184 | (1) Trifluoperazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Trifluoperazine Tablets, B.P. | Chorea |
| Hyperactive states of organic or toxic delirium | |
|
| Major psychoses including |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic-depressive psychosis |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients who have not attained the age of 16 years |
185 | Triglycerides Oil, Medium Chain | With the written authority of the Permanent Head, patients requiring a ketogenic diet for intractable childhood epilepsy |
186 | “ TRIGLYDE ”............ | Steatorrhoea due to extensive small bowel resection |
|
| With the written authority of the Permanent Head— |
|
| Patients requiring a ketogenic diet for intractable childhood epilepsy |
|
| Proven malabsorption |
187 | Trioxysalen.............. | Vitiligo |
188 | Vancomycin Hydrochloride.... | Any disease or condition in a patient receiving treatment in a hospital |
|
| Endophthalmitis |
189 | Verapamil Hydrochloride..... | Cardiac arrhythmias |
190 | “ ZERODOR ”............ | Ileostomy or colostomy conditions |
191 | “ ZOFF ”................ | Any disease or condition in a paraplegic or quadriplegic patient |
|
| For use with surgical appliances |
|
| Ileostomy or colostomy conditions |
Printed by Authority by the Commonwealth Government Printer